Nebula Research & Development LLC Cv Rx, Inc. Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 13,418 shares of CVRX stock, worth $190,535. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,418
Previous 13,371
0.35%
Holding current value
$190,535
Previous $160 Million
26.26%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
83Shares Held
13.6MCall Options Held
49.9KPut Options Held
2.1K-
Johnson & Johnson New Brunswick, NJ4.1MShares$58.3 Million11.52% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$33.7 Million1.6% of portfolio
-
Black Rock Inc. New York, NY876KShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$11.7 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT683KShares$9.7 Million0.85% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $292M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...